Amphista Therapeutics Limited

Amphista is identifying and advancing novel approaches in targeted protein degradation (TPD) to develop a new generation of innovative therapies with significantly improved efficacy.

Stay up to date with Amphista Therapeutics Limited

Login or create a free user account to follow this company and see updates on your dashboard.

Create account